Bioventus Inc (BVS)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SERVICES
SIC:
CEO:
Kenneth M. Reali
Employees:
1,200
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC 27703
(919) 474-6700

Bioventus Inc. focuses on developing and commercializing treatments that engage and enhance the body's natural healing process. The company's portfolio of products includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions include bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries. Restorative therapies comprise an ultrasonic bone healing system for fracture care.

Data derived from most recent annual or quarterly report
Market Cap 0 Shares Outstanding0 Avg 30-day Volume 141.517 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price to Revenue0.8796 Debt to Equity0.7189 EBITDA13.933 Million
Price to Book Value0.9757 Operating Margin-5.8268 Enterprise Value763.792 Million
Current Ratio1.394 EPS Growth-1.75 Quick Ratio0.925
1 Yr BETA 1.0028 52-week High/Low 17.53 / 6.3 Profit Margin-5.4298
Operating Cash Flow Growth-87.6599 Altman Z-Score0.7555 Free Cash Flow to Firm -538.835 Million
View SEC Filings from BVS instead.

View recent insider trading info

Funds Holding BVS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BVS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

SUTTER MARTIN P

  • Director
16,648 2022-06-17 3

HAWKINS WILLIAM A

  • Director
16,648 2022-06-17 4

NOHRA GUY P

  • Director
16,648 2022-06-17 3

STALNECKER SUSAN M

  • Director
16,648 2022-06-17 3

NEELS GUIDO J

  • Director
16,648 2022-06-17 3

VIZIRGIANAKIS STAVROS G.

  • Director
2,800,466 2022-06-16 4

BEYER PAT

  • Director
19,543 2022-06-16 3

LADONE MARY KAY

  • Director
22,088 2022-06-16 1

MCMURRY-HEATH MICHELLE

  • Director
17,805 2022-06-16 3

SINGLETON MARK LEONARD SVP & CFO

  • Officer
297,700 2022-04-04 2

COWDY PHILIP G.

  • Director
11,700 2022-04-01 2

D'ADAMIO ANTHONY SVP & GENERAL COUNSEL

  • Officer
96,280 2022-04-01 3

PAVESIO ALESSANDRA SVP & CHIEF SCIENCE OFFICER

  • Officer
329,615 2022-04-01 4

NOSENZO JOHN CHIEF COMMERCIAL OFFICER

  • Officer
233,827 2022-04-01 3

ANGLUM GREGORY O. SVP & CFO

  • Officer
111,320 2022-02-11 2

REALI KENNETH MICHAEL CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
11,175 2021-09-09 0

PARKER DAVID J

  • Director
2,700 2021-04-01 0

CHURCH KATRINA J SVP & CHIEF COMPLIANCE OFFICER

  • Officer
2,500 2021-02-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
BIOVENTUS INC - A BVS 2022-10-05 22:15:03 UTC 2.5256 0.5444 450000
BIOVENTUS INC - A BVS 2022-10-05 21:45:03 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 21:15:04 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 20:45:03 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 20:15:04 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 19:45:04 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 19:15:04 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 18:45:03 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 18:15:03 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 17:45:03 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 17:15:03 UTC 2.5311 0.5389 450000
BIOVENTUS INC - A BVS 2022-10-05 16:45:04 UTC 2.5115 0.5585 450000
BIOVENTUS INC - A BVS 2022-10-05 16:15:03 UTC 2.5115 0.5585 450000
BIOVENTUS INC - A BVS 2022-10-05 15:45:03 UTC 2.5115 0.5585 450000
BIOVENTUS INC - A BVS 2022-10-05 15:15:03 UTC 2.5115 0.5585 450000
BIOVENTUS INC - A BVS 2022-10-05 14:45:03 UTC 2.5115 0.5585 450000
BIOVENTUS INC - A BVS 2022-10-05 14:15:03 UTC 2.5115 0.5585 450000
BIOVENTUS INC - A BVS 2022-10-05 13:45:03 UTC 2.4935 0.5765 450000
BIOVENTUS INC - A BVS 2022-10-05 13:15:03 UTC 2.4935 0.5765 450000
BIOVENTUS INC - A BVS 2022-10-05 12:45:03 UTC 2.4935 0.5765 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund BVS -1100.0 shares, $-7502.0 2022-06-30 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments